GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » Buyback Yield %

Clearbridge Health (SGX:1H3) Buyback Yield % : 0.00 (As of Jun. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Clearbridge Health's current buyback yield was 0.00%.


Clearbridge Health Buyback Yield % Historical Data

The historical data trend for Clearbridge Health's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health Buyback Yield % Chart

Clearbridge Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.86 - - - -

Clearbridge Health Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Clearbridge Health's Buyback Yield %

For the Diagnostics & Research subindustry, Clearbridge Health's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearbridge Health's Buyback Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's Buyback Yield % falls into.



Clearbridge Health Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Clearbridge Health's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 9.904832
=0.00%

Clearbridge Health's annualized Buyback Yield for the quarter that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 2 / 9.904832
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Dec. 2023) data.


Clearbridge Health Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearbridge Health (SGX:1H3) Business Description

Traded in Other Exchanges
N/A
Address
37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines